Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma

About 50% of melanomas harbour a BRAF mutation. Of these 50%, 10% have a V600K mutation. Although it is the second most common driver mutation after V600E, no specific studies have been conducted to identify a clinical and therapeutic gold standard for this patient subgroup. We analysed articles, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nepote, Alessandro, Avallone, Gianluca, Ribero, Simone, Cavallo, Francesco, Roccuzzo, Gabriele, Mastorino, Luca, Conforti, Claudio, Paruzzo, Luca, Poletto, Stefano, Schianca, Fabrizio Carnevale, Quaglino, Pietro, Aglietta, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836712/
https://www.ncbi.nlm.nih.gov/pubmed/35160279
http://dx.doi.org/10.3390/jcm11030828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836712/
https://www.ncbi.nlm.nih.gov/pubmed/35160279
http://dx.doi.org/10.3390/jcm11030828

Ejemplares similares